Home » DRUG MAKER WARNS CANCER DRUG MAY DECREASE HEART FUNCTION IN SOME PATIENTS
DRUG MAKER WARNS CANCER DRUG MAY DECREASE HEART FUNCTION IN SOME PATIENTS
Drug maker Novartis issued a warning Monday that the cancer drug Gleevec could lead to decreased heart function in some patients.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct